Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL, sterile injectable, ST3:Papaverine 40mg/Phentolamine 3mg/Prostaglandin 60mcg/mL, Vitalab Pharmacy, Inc.
Published May 16, 2018 · Recall initiated: April 24, 2018
Summary
FDA records drug Class II recall D-0732-2018, published May 16, 2018 and initiated April 24, 2018. Recalling firm: Vitalab Pharmacy, Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 03052018@54. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Vitalab Pharmacy, Inc
- Distributor
- The recalled product was distributed to patients throughout the United States.
- Lot
- Lot #: 03052018@54
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMethylcobalamin for injection, 1mg/mL and 10 mg/mL, Sterile injectable, Vitalab Pharmacy, IncMay 16, 2018
- FDAMethionine 25mg/Inositol 50mg/Choline 50mg/Cyanocobalamin 1mg/ml, Sterile injectable, Vitalab Pharmacy, IncMay 16, 2018
- FDAPapaverine 9mg/Phentolamine 1mg/Atropine 0.1mg/Prostaglandinl 10mcg/ml, sterile injectable, Vitalab Pharmacy,May 16, 2018
- FDAPapaverine 30mg/Phentolamine 2mg/Prostaglandin 20mcg/mL, Papaverine 30mg/Phentolamine 1mg/ProstaglandinMay 16, 2018
- FDAHumira Pen Sub-q Kit a.) 40 mg/0.8 mL (NDC 00074-4339-02); Humira Pen Psor Kit b.) 40 mg/0.8 mL (NDCMay 16, 2018
- FDAKalydeco 150 mg tablet blister, 28 days supply, Rx Only, 39183, NDC 51167-0200-01May 16, 2018
Questions about this recall
Was Papaverine 30mg/Phentolamine 1.5mg/Prostaglandin 50mcg/mL, sterile injectable, ST3:Papaverine 40mg/Phentolamine 3mg/Prostaglandin 60mcg/mL, Vitalab Pharmacy, Inc. recalled?
Yes. FDA published recall D-0732-2018 on May 16, 2018. Reported hazard: Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.
What should I do if I have this product?
Voluntary: Firm initiated · Letter